SynthesisFrontiers in medicine2025

Efficacy and safety of ruxolitinib for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.

Chunhong Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.